Page last updated: 2024-11-08

thiophosphoric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thiophosphoric acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID167254
CHEBI ID46611
CHEBI ID46613
MeSH IDM0109092

Synonyms (27)

Synonym
p(s)(oh)3
thiophosphoric acid
CHEBI:46611
phosphorothioic acid
thiophosphoric o,o,s-acid
phosphorothioic o,o,s-acid
p(o)(oh)2(sh)
phosphorothioic o,o,o-acid
CHEBI:46613
dihydroxidooxidosulfanidophosphorus
thiophosphoric o,o,o-acid
13598-51-1
phosphorothionic acid
trihydroxidosulfidophosphorus
monothiophosphoric acid
ts6 ,
monothiophosphate
tym4m7ewcw ,
unii-tym4m7ewcw
thiophosphoric acid (h3po3s)
DTXSID8074948
'phosphorothioic o,o,s-acid'
FT-0701045
FT-0701046
Q2421303
trihydroxy(sulfanylidene)-lambda5-phosphane
FT-0778017

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"This study presents in silico prediction of toxic activities and carcinogenicity, represented by the potential carcinogenicity DSSTox/DBS, based on vector regression with a new Kernel activity, and correlating the predicted toxicity values through a QSAR model, namely: QSTR/QSCarciAR (quantitative structure toxicity relationship/quantitative structure carcinogenicity-activity relationship) described by 2D, 3D descriptors and biological descriptors."( Potential carcinogenicity predicted by computational toxicity evaluation of thiophosphate pesticides using QSTR/QSCarciAR model.
Ilia, G; Petrescu, AM, 2017
)
0.46

Compound-Compound Interactions

ExcerptReferenceRelevance
" Moreover, more information can be provided on the evaluation of toxicity of phorate using metabonomics combined with clinical chemistry."( Metabonomics evaluation of urine from rats administered with phorate under long-term and low-level exposure by ultra-performance liquid chromatography-mass spectrometry.
Guo, L; Hou, Y; Sun, C; Sun, X; Xu, W; Zeng, Y; Zhao, X, 2014
)
0.4

Bioavailability

ExcerptReferenceRelevance
" Following oral administration, all three metabolites were well absorbed with peak blood concentrations being attained between 1 and 3h post-dosing."( Comparative pharmacokinetics of the organophosphorus insecticide chlorpyrifos and its major metabolites diethylphosphate, diethylthiophosphate and 3,5,6-trichloro-2-pyridinol in the rat.
Barr, DB; Busby, A; Campbell, JA; Needham, LL; Timchalk, C, 2007
)
0.34

Dosage Studied

ExcerptRelevanceReference
" We also examined the cytotoxicity and dose-response using several thiophosphate modified siRNAs with unmodified siRNA."( The effects of thiophosphate substitutions on native siRNA gene silencing.
Gorenstein, DG; Kallick, DA; Li, ZY; Mao, H, 2005
)
0.33
" The objective of the current study was to compare the pharmacokinetics of orally administered DEP, DETP and TCPy with their kinetics following oral dosing with the parent insecticide CPF in the rat."( Comparative pharmacokinetics of the organophosphorus insecticide chlorpyrifos and its major metabolites diethylphosphate, diethylthiophosphate and 3,5,6-trichloro-2-pyridinol in the rat.
Barr, DB; Busby, A; Campbell, JA; Needham, LL; Timchalk, C, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phosphorothioic acid
phosphorothioic acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (260)

TimeframeStudies, This Drug (%)All Drugs %
pre-199073 (28.08)18.7374
1990's30 (11.54)18.2507
2000's53 (20.38)29.6817
2010's68 (26.15)24.3611
2020's36 (13.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.76 (24.57)
Research Supply Index5.62 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.36%)5.53%
Reviews8 (2.92%)6.00%
Case Studies1 (0.36%)4.05%
Observational0 (0.00%)0.25%
Other264 (96.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]